Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

241 projects found matching your search criteria :

  1. Computational modeling of tumor angiogenesis: simulation of abnormal vascular morphogenesis

    Call: PRELUDIUM 24 , Panel: ST3

    Principal investigator: Antoni Maria Wrzos

    Uniwersytet Warszawski

  2. CTC-on-CAM: a platform for studying heterogeneity, epithelial-mesenchymal transition, and therapeutic sensitivity of cir...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: prof. Marek Arkadiusz Murias

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  3. Mini-tumors, big answers: Modeling of immune system's activation with organoid-based PDT-on-Chip technology

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Marta Karolina Warszyńska

    Uniwersytet Jagielloński

  4. Rola TRIM32 i TRIM34 w regulacji metabolizmu guza i mikrośrodowiska immunologicznego w raku jajnika

    Call: PRELUDIUM 24 , Panel: NZ6

    Principal investigator: Alicja Katarzyna Rajtak

    Uniwersytet Medyczny w Lublinie

  5. We are Left Without Oxygen—Now What?: Evaluation of Hypoxia-Inducible COL Family Genes in Glioblastoma Patients and Thei...

    Call: OPUS 29 , Panel: NZ4

    Principal investigator: prof. Ewa Izabela Balcerczak

    Uniwersytet Medyczny w Łodzi

  6. Influence of ER stress on the hormonal activity of pituitary neuroendocrine tumors (PitNETs)

    Call: SONATINA 9 , Panel: NZ4

    Principal investigator: dr Beata Krystyna Rak-Makowska

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  7. Novel insights into inhibition of PD-L1/PD-1 immune checkpoint – discovery and optimization of covalent PD-L1 inhibitors...

    Call: SONATA 20 , Panel: ST5

    Principal investigator: dr Radosław Dariusz Kitel

    Uniwersytet Jagielloński

  8. Investigation of the mechanism of enhanced liposome delivery to tumors and its application for dual target immunotherapy

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Piotr Rygiel

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  9. Neutrophil Dynamics: Unveiling Anti-Tumor and Therapy Efficacy with the TUmor Neutrophil Immunotherapy on Chip (TUNIC) m...

    Call: SONATA 20 , Panel: NZ6

    Principal investigator: dr Martin Nurmik

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  10. Aptamer-mediated SERS/DEP Biosensors for proteomic analysis of extracellular vesicles of salivary gland tumors: towards ...

    Call: OPUS 28 , Panel: ST4

    Principal investigator: prof. Agnieszka Edyta Michota-Kamińska

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

  11. Exploring DMRTA2 in Glioblastoma: Epigenetic Regulation, Angiogenesis Disruption, and Biomarker Development

    Call: SONATA BIS 14 , Panel: NZ3

    Principal investigator: dr Marta Magdalena Maleszewska-Bobińska

    Uniwersytet Warszawski

  12. Quad-TNT: Quadruplex-Targeted Photo-Therapy for Triple-Negative Tumors

    Call: SONATA BIS 14 , Panel: NZ5

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

  13. Cellular effects in the tumor microenvironment and the potential for targeted delivery of molecules associated with the ...

    Call: OPUS 27 , Panel: NZ4

    Principal investigator: prof. Magdalena Maria Staniszewska

    Katolicki Uniwersytet Lubelski Jana Pawła II

  14. The comprehensive molecular and clinical characterization of Crooke's cell corticotroph pituitary tumors

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Szymon Piotr Baluszek

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

  15. Diffusion magnetic resonance imaging for accurate white matter tracking in peritumoral tissue to enhance surgical planni...

    Call: PRELUDIUM 23 , Panel: NZ4

    Principal investigator: Joan Falcó-Roget

    Sano - Centrum Zindywidualizowanej Medycyny Obliczeniowej - Międzynarodowa Fundacja Badawcza

  16. Small molecule modulators of the tumor necrosis factor alpha signaling pathway for the inhibition of inflammatory proces...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Tadeusz Holak

    Uniwersytet Gdański

  17. Identification of novel microRNA biomarkers in liquid biopsy of patients with neuroendocrine tumors

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Paweł Mateusz Komarnicki

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  18. The two are better than one - biferrocenyl ROS generators as intelligent anticancer agents

    Call: OPUS 27 , Panel: ST5

    Principal investigator: prof. Konrad Maciej Kowalski

    Uniwersytet Łódzki

  19. Search for new biomarkers useful in the diagnosis of adrenal tumors based on the analysis of selected metabolomic profil...

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Alicja Szatko

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  20. The Prognostic Utility of Circulating Tumor Cells (CTCs) Derived from the Portal Vein in Operable Colorectal Cancer Pati...

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Claudia Dompé

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  21. Interrogation of the antigen presentation dynamics via MHCII in tumor immune evasion through multimodal single-cell sequ...

    Call: SONATINA 8 , Panel: NZ2

    Principal investigator: dr Natalia Ochocka-Lewicka

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

  22. Computational methods for understanding tumor immune microenvironment from spatial imaging data

    Call: SONATA 19 , Panel: NZ2

    Principal investigator: dr Krzysztof Kamil Gogolewski

    Uniwersytet Warszawski, Wydział Matematyki, Informatyki i Mechaniki

  23. Defining the transcriptional and epigenetic state of tumor cells with increased plasticity and the epithelial-endothelia...

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr hab. Agnieszka Kobielak

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  24. Tumor viscoelasticity as a central player in glioblastoma treatment - towards mechanopharmacology

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Pogoda

    Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego PAN

  25. Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Magdalena Wujak

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

  26. Exploring the influence of genomic features on mutational signatures across tumors

    Call: OPUS 26 , Panel: NZ2

    Principal investigator: dr Damian Michał Wójtowicz

    Uniwersytet Warszawski, Wydział Matematyki, Informatyki i Mechaniki

  27. Cannabidiol as a modulator of radiological response in the therapy of peripheral nervous system tumors - lipidomics from...

    Call: SONATA 19 , Panel: ST4

    Principal investigator: dr Karolina Anna Chrabąszcz

    Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego PAN

  28. Increasing sensitivity to immunotherapy in lung cancer via immunostimulation and modulation of tumor microenvironment

    Call: SONATA BIS 13 , Panel: NZ5

    Principal investigator: dr Urszula Oleksiewicz

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  29. Design and Development of Serine Hydroxymethyltransferase-2 (SHMT2) Inhibitors Blocking Tumor Growth

    Call: SONATA BIS 13 , Panel: NZ7

    Principal investigator: dr hab. Miłosz Ruszkowski

    Instytut Chemii Bioorganicznej PAN

  30. Searching for novel regulators of antitumor immune response

    Call: MAESTRO 15 , Panel: NZ6

    Principal investigator: dr hab. Magdalena Hanna Winiarska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  31. Development of novel bifunctional ceramic coatings with osteoinductive and anti-oncogenic properties on metallic implant...

    Call: PRELUDIUM 22 , Panel: ST5

    Principal investigator: Balbina Karina Makurat-Kasprolewicz

    Politechnika Gdańska

  32. Molecular mechanisms of DNA damage triggered by PIM kinases inhibition and its consequences for activation of innate imm...

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: prof. Przemysław Juszczyński

    Instytut Hematologii i Transfuzjologii

  33. Investigating mechanisms regulating ALCAM alternative splicing and susceptibility of this molecule to cleavage by shedda...

    Call: OPUS 25 , Panel: NZ2

    Principal investigator: dr Marta Karolina Wagner

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  34. Functional consequences of loss of chromosome Y (LOY) in immune cells in the context of cancer - ex vivo and in vitro st...

    Call: OPUS 25 , Panel: NZ2

    Principal investigator: dr Jan Dumański

    Gdański Uniwersytet Medyczny, Międzynarodowa Agenda Badawcza

  35. Molecular profiling of soft tissue sarcomas in tumor and peripheral blood in terms of response to treatment and early de...

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: prof. Piotr Łukasz Rutkowski

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

  36. Assessing ovarian cancer molecular heterogeneity by NMR-based metabolomics, spatially resolved transcriptomics and metab...

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: prof. Maria Bożena Sokół

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

  37. Targeting undruggable proteins involved in tumorigenesis – developing and characterization of advanced nanoplatform for ...

    Call: OPUS 25 , Panel: NZ6

    Principal investigator: dr hab. Monika Bzowska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Bitechnologii

  38. 3D-printed bone implants - Exploring the relationship between the chemical and spatial structure of implants and their s...

    Call: OPUS 25 , Panel: ST4

    Principal investigator: prof. Edyta Proniewicz

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie, Wydział Odlewnictwa

  39. Ultrasensitive profiling of mutations driving tumorigenesis in hereditary syndromes associated with tumor suppressor gen...

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: dr Katarzyna Klonowska

    Instytut Chemii Bioorganicznej PAN

  40. Spatial Determinants of Immunotherapy Resistance in Cancer

    Call: WEAVE-UNISONO , Panel: NZ6

    Principal investigator: dr Marcin Tabaka

    Instytut Chemii Fizycznej Polskiej Akademii Nauk, Międzynarodowe Centrum Badań Oka

  41. Unveiling the molecular signature underlying resistance to CD19 CAR-T therapy in malignant cells.

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Marta Krawczyk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  42. Participation of exosomes secreted by neutrophils in the modulation of angiogenesis - the role of the type 1 interferon ...

    Call: SONATINA 7 , Panel: NZ5

    Principal investigator: dr Mateusz Piotr Smolarz

    Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach

  43. Precise molecular characterization of circulating tumour cells in patients with triple negative breast cancer using high...

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: prof. Stefano Volinia

    Uniwersytet Warszawski, Centrum Nauk Biologiczno-Chemicznych

  44. Targeted poloxamer micelles with selected drugs as a strategy for overcoming the mechanisms of multidrug resistance in p...

    Call: PRELUDIUM BIS 4 , Panel: NZ7

    Principal investigator: prof. Tomasz Adam Gośliński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  45. Molecular insights into hypoxic tumors – for development of targeted cancer therapeutics

    Call: POLONEZ BIS 3 , Panel: NZ5

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

  46. Three-dimensional mass spectrometry imaging system (3D MSI)

    Call: SONATA BIS 12 , Panel: ST4

    Principal investigator: dr hab. Joanna Nizioł

    Politechnika Rzeszowska im. Ignacego Łukasiewicza, Wydział Chemiczny

  47. CO-TARGETING OF TUMOR MICROENVIRONMENT-MEDIATED ADAPTATION TO HYPOXIA RENDERS GLIOBLASTOMA MORE SUSCEPTIBLE TO ONCOLYTIC...

    Call: OPUS 23 , Panel: NZ5

    Principal investigator: dr hab. Agnieszka Marta Bronisz

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  48. Pancreatic cancer oxygenation as a prognostic marker during anticancer therapy

    Call: OPUS 23 , Panel: NZ5

    Principal investigator: dr Martyna Krzykawska-Serda

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  49. Phagocytic cells as boron carriers in boron neutron capture therapy

    Call: PRELUDIUM 21 , Panel: NZ5

    Principal investigator: Anna Maria Rudawska

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  50. Depletion of the tumor microenvironment as a novel strategy potentiating the efficacy of immunotherapies.

    Call: OPUS 23 , Panel: NZ6

    Principal investigator: dr Małgorzata Agnieszka Bajor

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy